Ignite Creation Date:
2024-05-05 @ 11:12 PM
Last Modification Date:
2024-10-26 @ 10:29 AM
Study NCT ID:
NCT01272258
Status:
WITHDRAWN
Last Update Posted:
2017-02-02
First Post:
2011-01-05
Brief Title:
A Trial of Observed Long-acting Anti-HIV Treatment With a Monoclonal CCR5 Antibody PRO 140 as an Adjunct to a New Optimized Oral Antiretroviral Regimen in HIV-infected Injection Drug Users With Viral Rebound and Documented Poor Adherence
Sponsor:
Organization:
CytoDyn Inc